Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling

International Journal of Biochemistry and Cell Biology

Volumn 33, Issue 1, 2001, Pages 19-32

  Wajant, Harald ^a   Scheurich, Peter ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Apoptosis; JNK; NF B; TNF receptor associated factor (TRAF) 2

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; JANUS KINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ENZYME ACTIVATION; IMMUNOREGULATION; INFLAMMATION; PROTEIN DOMAIN; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL SURVIVAL; HUMANS; LIGANDS; MODELS, BIOLOGICAL; MUTATION; NF-KAPPA B; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2;

EID: 0035122689     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00064-9     Document Type: Review

References (104)

1. Cell death induction by receptors of the TNF family: Towards a molecular understanding
2. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
3. Structure of tumour necrosis factor
4. Crystal structure of the soluble human 55 kd TNF receptor-human TNF-β complex: Implications for TNF receptor activation
5. Modularity in the TNF-receptor family
6. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
7. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor
8. Fas pre-association required for apoptosis signalling and dominant inhibition by pathogenic mutations
9. Tumor necrosis factor
10. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
11. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor
12. Death receptors: Signaling and modulation
13. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
14. TRAF 6 is a signal transducer for interleukin-1
15. Requirement of tumor necrosis factor receptor-associated factor (TRAF) 6 in interleukin-17 signal transduction
16. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF 2 recruitment to the IL-15Ralpha chain
17. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
18. TNF receptor-associated factors in cytokine signaling
19. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
20. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
21. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
22. TRADD-TRAF 2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
23. Structural basis for self-association and receptor recognition of human TRAF 2
24. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF 2 interaction
25. The distinct roles of TRAF 2 and RIP in IKK activation by TNF-R1: TRAF 2 recruits IKK to TNF-R1 while RIP mediates IKK activation
26. The tumor necrosis factor receptor 2 signal transducers TRAF 2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex
27. The TNFR 2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
28. NF-κB antiapoptosis: Induction of TRAF 1 and TRAF 2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
29. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
30. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1
31. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
32. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
33. The inhibitor of apoptosis, cIAP1, functions as a ubiquitin-protein ligase and promotes in vitro ubiquitination of caspases -3 and -7
34. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
35. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-κB activation
36. The IKK complex: An integrator of all signals that activate NF-κB
37. Multiple signals converging on NF-κB
38. How NF-κB is activated: The role of the I-κB kinase (IKK) complex
39. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40
40. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
41. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-κB activation but is dispensable for c-Jun N-terminal kinase signaling
42. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival
43. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
44. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor κB pathways
45. The death domain kinase RIP mediates the TNF-induced NF-κB signal
46. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation
47. Impaired TNF-induced NF-κB activation and high sensitivity to TNF-induced cell death in TRAF2- and TRAF5-double deficient mice
48. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation
49. From receptors to stress-activated MAP kinases
50. A novel SAPK/JNK kinase, MKK7, stimulated by TNF-α and cellular stresses
51. ASK1 is essential for JNK/SAPK activation by TRAF2
52. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway
53. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
54. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration
55. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38
56. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression
57. TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-κB activation
58. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction
59. TANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase/stress-activated protein kinase activation through the germinal center kinase pathway
60. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1 a novel IKK-related kinase
61. The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN
62. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF 1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-(B and c-Jun N-terminal kinase
63. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
64. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop
65. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis
66. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis
67. Apoptosis promotes a caspase-induced amino-terminal truncation of IκBα that functions as a stable inhibitor of NF-κB
68. CD30-dependent degradation of TRAF2: Implications for negative regulation of TRAF signaling and the control of cell survival
69. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: Requirement of the TNF receptor-associated factor-2 binding site
70. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60
71. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes
72. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
73. Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein
74. CD30/TNF receptor-associated factor interaction: NF-κ B activation and binding specificity
75. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors
76. Assembly and regulation of the CD40 receptor complex in human B cells
77. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB
78. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation
79. The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2
80. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor
81. Characterization of the intracellular domain of receptor activator of NF-κB (RANK). Interaction with tumor necrosis factor receptor- associated factors and activation of NF-κB and c-Jun N-terminal kinase
82. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase. Identification of a novel TRAF6 interaction motif
83. Herpes virus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth
84. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5
85. TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction
86. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand
87. TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase- independent cell death
88. TRAF-interacting protein (TRIP): A novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation
89. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation
90. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-κB activation
91. Peg3/Pw1 is an imprinted gene involved in the TNF-NFkappaB signal transduction pathway
92. Casper is a FADD- and caspase-related inducer of apoptosis
93. Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2
94. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
95. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
96. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1
97. Binding of CDK9 to TRAF2
98. TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton
99. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses
100. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase
101. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses
102. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
103. Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development
104. An essential role for NF-κB in preventing TNF-alpha-induced cell death